Who
Geoffrey Nichol
Director
Company insider
Files Form 4 as: Director, Tempest Therapeutics; Executive Vice President, R&D, Sangamo Biosciences; Senior Vice President, Medarex.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 9 Sep 2002
- Last trade
- 27 Jan 2026
- Last filed
- 28 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Jan 2026filed 28 Jan 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,230 at $0.00 | filing |
| 27 Jan 2026filed 28 Jan 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,230 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,200 at $0.00 | filing |
| 17 Jun 2022filed 22 Jun 2022 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,500 at $0.00 | filing |
| 1 Jul 2021filed 20 Sep 2021 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,635 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,635 | filing |
| 22 Jun 2020filed 23 Jun 2020 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 17 Dec 2019filed 19 Dec 2019 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 12 Dec 2015filed 15 Dec 2015 | Sangamo Biosciences | SEC FORM 4 Code F | $38K4,384 at $8.68 | filing |
| 11 Dec 2015filed 15 Dec 2015 | Sangamo Biosciences | SEC FORM 4 Code F | $41K4,697 at $8.68 | filing |
| 8 Dec 2015filed 9 Dec 2015 | Sangamo Biosciences | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 8 Dec 2015filed 9 Dec 2015 | Sangamo Biosciencesoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 7 Dec 2015filed 9 Dec 2015 | Sangamo Biosciences | SEC FORM 4 Code F | $67K6,889 at $9.69 | filing |
| 15 Dec 2014filed 15 Dec 2014 | Sangamo Biosciences | SEC FORM 4 Code F | $615K41,743 at $14.74 | filing |
| 11 Dec 2014filed 15 Dec 2014 | Sangamo Biosciences | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 11 Dec 2014filed 15 Dec 2014 | Sangamo Biosciencesoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 12 Dec 2013filed 13 Dec 2013 | Sangamo Biosciencesoption or derivative | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 12 Dec 2013filed 13 Dec 2013 | Sangamo Biosciences | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 12 Dec 2013filed 13 Dec 2013 | Sangamo Biosciences | SEC FORM 4 Code F | $274K22,611 at $12.12 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.